"Inflammation Mediators" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The endogenous compounds that mediate inflammation (AUTACOIDS) and related exogenous compounds including the synthetic prostaglandins (PROSTAGLANDINS, SYNTHETIC).
| Descriptor ID |
D018836
|
| MeSH Number(s) |
D23.469
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Inflammation Mediators".
Below are MeSH descriptors whose meaning is more specific than "Inflammation Mediators".
This graph shows the total number of publications written about "Inflammation Mediators" by people in this website by year, and whether "Inflammation Mediators" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 0 | 1 |
| 1999 | 2 | 0 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 2 | 3 |
| 2003 | 2 | 1 | 3 |
| 2005 | 0 | 3 | 3 |
| 2007 | 2 | 2 | 4 |
| 2008 | 2 | 2 | 4 |
| 2009 | 4 | 4 | 8 |
| 2010 | 0 | 3 | 3 |
| 2011 | 2 | 4 | 6 |
| 2012 | 1 | 12 | 13 |
| 2013 | 3 | 6 | 9 |
| 2014 | 2 | 6 | 8 |
| 2015 | 3 | 5 | 8 |
| 2016 | 2 | 5 | 7 |
| 2017 | 3 | 6 | 9 |
| 2018 | 2 | 7 | 9 |
| 2019 | 1 | 3 | 4 |
| 2020 | 3 | 6 | 9 |
| 2021 | 2 | 4 | 6 |
| 2022 | 0 | 1 | 1 |
| 2024 | 0 | 2 | 2 |
| 2025 | 0 | 2 | 2 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Inflammation Mediators" by people in Profiles.
-
Anti-Malignancy and Anti-Inflammation Properties of Emodin, an Essential Constituent in Popular Laxative Botanicals. Am J Chin Med. 2026; 54(5):1585-1605.
-
The role of inflammation in longitudinal renal function decline and incident chronic kidney disease: the multi-ethnic study of atherosclerosis. Eur J Prev Cardiol. 2026 Mar 27; 33(5):718-728.
-
Influence of Weight Loss and Weight Regain on Adipose Tissue Inflammation. Arterioscler Thromb Vasc Biol. 2025 12; 45(12):2155-2163.
-
Association between dietary folate and hyperuricemia based on inflammation and cardiovascular disease status. Nutr Metab Cardiovasc Dis. 2025 Sep; 35(9):104108.
-
Obesity induces PD-1 on macrophages to suppress anti-tumour immunity. Nature. 2024 06; 630(8018):968-975.
-
Inhibition of oxidized low-density lipoprotein with orticumab inhibits coronary inflammation and reduces residual inflammatory risk in psoriasis: a pilot randomized, double-blind placebo-controlled trial. Cardiovasc Res. 2024 05 29; 120(7):678-680.
-
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer. Clin Lung Cancer. 2022 11; 23(7):e489-e499.
-
MTHFD2 is a metabolic checkpoint controlling effector and regulatory TÂ cell fate and function. Immunity. 2022 01 11; 55(1):65-81.e9.
-
Differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis. Sci Rep. 2021 09 15; 11(1):18399.
-
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results. Blood. 2021 07 08; 138(1):11-22.